Xenon Pharmaceuticals
XENE
$43.75
Share price
1.74%
Change (1 day)
7.28%
Change (1 year)
Categories
Xenon Pharmaceuticals (XENE) - Total debt
Total debt on the balance sheet as of December 2023 : $10.9 M
According to Xenon Pharmaceuticals's latest financial reports the company's total debt is $10.9 M. A company’s total debt is the sum of all current and non-current debts.
Xenon Pharmaceuticals - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $10.9 M | 4.48% |
| 2022-12-31 | $10.43 M | 26.38% |
| 2021-12-31 | $8.25 M | 149.08% |
| 2020-12-31 | $3.31 M | -79.85% |
| 2019-12-31 | $16.45 M | 9.56% |
| 2018-12-31 | $15.01 M | 120.66% |
| 2017-12-31 | $6.8 M | |
| 2012-12-31 | $1.66 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Coherus BioSciences
CHRS | $0.48 B | 4,310.18% | 🇺🇸 USA |
 Atara Biotherapeutics ATRA | $57.87 M | 430.79% | 🇺🇸 USA |